Open AccessBalance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
Author(s) -
Jiang Wang,
Nan Li,
Feng Gao,
Song Rong,
Shanjun Zhu,
Zhaohua Geng
Publication year - 2015
Publication title -
journal of the renin-angiotensin-aldosterone system
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 46
eISSN - 1752-8976
pISSN - 1470-3203
DOI - 10.1177/1470320315576257
Subject(s) - heart failure , angiotensin converting enzyme 2 , medicine , renin–angiotensin system , angiotensin converting enzyme , dilated cardiomyopathy , endocrinology , angiotensin ii , cardiology , aldosterone , blood pressure , disease , covid-19 , infectious disease (medical specialty)
It has been reported that angiotensin converting enzyme 2 (ACE2) is an endogenous counter-regulator of the renin-angiotensin-aldosterone system. However, angiotensin converting enzyme (ACE)/ACE2 balance in the development of human heart failure is not well established.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom